SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Roof who wrote (967)1/27/1999 6:01:00 PM
From: Scott H. Davis  Read Replies (2) of 1972
 
Remember its a 2 year target, based on the expectation (I assume) that they've completed trials on a couple things and gotten and FDA approval, or appear very likely to get one. Development stage biotechs just don't fetch that kinda valuation. We're the gutsy ones, more money will come in as the perceived risk decreases. I think Lehman Bros target this year was $24. BA Robertson Stephens was also around there I believe. IMSCO Scott
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News